# \# 20190708170709 2000 Normal Functioning and the Treatment-Enhancement Distinction Daniels

\# \# 20190708170709 2000 Normal Functioning and the Treatment-Enhancement Distinction Daniels\
\# 20190708170709 2000 Normal Functioning and the Treatment-Enhancement Distinction Daniels tags= Daniels, 2000, Normal Functioning, Treatment-Enhancement Distinction\
PdfID=\
ï¼ƒFormatted Reference\
Daniels N. (2000) Normal Functioning and the Treatment-Enhancement Distinction. Cambridge Quarterly of Healthcare Ethics 9: 309-322.

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

\# Negative and Positive and the Permissible-Impermissible Boundary

\> \"Not all treatments will be permissible and not all enhancements will be impermissible\" \\(\\)

Moral Constraint: 1. Genetic intervention where the consent of the patient is not possible to obtain. Should we allow proxy consent providers such as parents for their babies?

\#Normal Functioning\# \#Daniels \#Treatment-Enhancement Distinction\# \#2000\#
